"CD56 Antigen" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The 140 kDa isoform of NCAM (neural cell adhesion molecule) containing a transmembrane domain and short cytoplasmic tail. It is expressed by all lymphocytes mediating non-MHC restricted cytotoxicity and is present on some neural tissues and tumors.
| Descriptor ID |
D019002
|
| MeSH Number(s) |
D12.776.395.550.200.250.520.156 D12.776.543.550.200.250.520.156 D23.050.301.264.894.156 D23.050.301.350.250.520.156 D23.101.100.894.156
|
| Concept/Terms |
CD56 Antigen- CD56 Antigen
- Antigen, CD56
- Leu-19 Antigen
- Antigen, Leu-19
- Leu 19 Antigen
- Antigens, CD56
- NKH-1 Antigen
- Antigen, NKH-1
- NKH 1 Antigen
- CD56 Antigens
|
Below are MeSH descriptors whose meaning is more general than "CD56 Antigen".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Glycoproteins [D12.776.395]
- Membrane Glycoproteins [D12.776.395.550]
- Cell Adhesion Molecules [D12.776.395.550.200]
- Cell Adhesion Molecules, Neuronal [D12.776.395.550.200.250]
- Neural Cell Adhesion Molecules [D12.776.395.550.200.250.520]
- CD56 Antigen [D12.776.395.550.200.250.520.156]
- Membrane Proteins [D12.776.543]
- Membrane Glycoproteins [D12.776.543.550]
- Cell Adhesion Molecules [D12.776.543.550.200]
- Cell Adhesion Molecules, Neuronal [D12.776.543.550.200.250]
- Neural Cell Adhesion Molecules [D12.776.543.550.200.250.520]
- CD56 Antigen [D12.776.543.550.200.250.520.156]
- Biological Factors [D23]
- Antigens [D23.050]
- Antigens, Surface [D23.050.301]
- Antigens, Differentiation [D23.050.301.264]
- Antigens, Differentiation, T-Lymphocyte [D23.050.301.264.894]
- CD56 Antigen [D23.050.301.264.894.156]
- Cell Adhesion Molecules [D23.050.301.350]
- Cell Adhesion Molecules, Neuronal [D23.050.301.350.250]
- Neural Cell Adhesion Molecules [D23.050.301.350.250.520]
- CD56 Antigen [D23.050.301.350.250.520.156]
- Biomarkers [D23.101]
- Antigens, Differentiation [D23.101.100]
- Antigens, Differentiation, T-Lymphocyte [D23.101.100.894]
- CD56 Antigen [D23.101.100.894.156]
Below are MeSH descriptors whose meaning is more specific than "CD56 Antigen".
This graph shows the total number of publications written about "CD56 Antigen" by people in this website by year, and whether "CD56 Antigen" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 1 | 0 | 1 |
| 2012 | 0 | 1 | 1 |
| 2013 | 0 | 2 | 2 |
| 2014 | 0 | 2 | 2 |
| 2017 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "CD56 Antigen" by people in Profiles.
-
CD56bright NK IL-7Ra expression negatively associates with HCV level, and IL-7-induced NK function is impaired during HCV and HIV infections. J Leukoc Biol. 2017 07; 102(1):171-184.
-
The natural killer cell interferon-gamma response to bacteria is diminished in untreated HIV-1 infection and defects persist despite viral suppression. J Acquir Immune Defic Syndr. 2014 Mar 01; 65(3):259-67.
-
Effects of cryopreservation on effector cells for antibody dependent cell-mediated cytotoxicity (ADCC) and natural killer (NK) cell activity in (51)Cr-release and CD107a assays. J Immunol Methods. 2014 Apr; 406:1-9.
-
GB virus C infection and B-cell, natural killer cell, and monocyte activation markers in HIV-infected individuals. AIDS. 2013 Jul 17; 27(11):1829-32.
-
CD160 activation by herpesvirus entry mediator augments inflammatory cytokine production and cytolytic function by NK cells. J Immunol. 2013 Jul 15; 191(2):828-36.
-
Baseline levels of soluble CD14 and CD16+56- natural killer cells are negatively associated with response to interferon/ribavirin therapy during HCV-HIV-1 coinfection. J Infect Dis. 2012 Sep 15; 206(6):969-73.
-
Increased IFN-gamma production by NK and CD3+/CD56+ cells in sexually HIV-1-exposed but uninfected individuals. Clin Immunol. 2006 Aug; 120(2):138-46.